Evidence map›Paper›PMID 34501689›Full record

ArticleInternational journal of environmental research and public health2021

Analysis of Risk Factors for Major Complications of 1500 Transvenous Lead Extraction Procedures with Especial Attention to Tricuspid Valve Damage.

Łukasz Tułecki, Anna Polewczyk, Wojciech Jacheć, Dorota Nowosielecka, Konrad Tomków, Paweł Stefańczyk, Jarosław Kosior, Krzysztof Duda, Maciej Polewczyk, Andrzej Kutarski

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. Review
  6. [Research of tricuspid regurgitation associated with cardiac implantable electronic devices].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a 'heart team' approach.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  11. Article
  12. Article
  13. Practical Approaches to Transvenous Lead Extraction Procedures-Clinical Case Series.International journal of environmental research and public health · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Tricuspid Valve Damage Related to Transvenous Lead Extraction.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Łukasz TułeckiDepartment of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, 22-400 Zamość, Poland.
Anna PolewczykDepartment of Physiology, Pathophysiology and Clinical Immunology Collegium Medicum, The Jan Kochanowski University, 25-369 Kielce, Poland.ORCID 0000-0002-6632-6551
Wojciech Jacheć2nd Department of Cardiology, Silesian Medical University, 41-808 Zabrze, Poland.ORCID 0000-0002-1091-9788
Dorota NowosieleckaDepartment of Cardiology, The Pope John Paul II Province Hospital of Zamość, 22-400 Zamość, Poland.
Konrad TomkówDepartment of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, 22-400 Zamość, Poland.
Paweł StefańczykDepartment of Cardiology, The Pope John Paul II Province Hospital of Zamość, 22-400 Zamość, Poland.ORCID 0000-0002-4106-3804
Jarosław KosiorDepartment of Cardiology, Masovian Specialist Hospital of Radom, 26-617 Radom, Poland.
Krzysztof DudaDepartment of Cardiac Surgery,Masovian Specialist Hospital of Radom, 26-617 Radom, Poland.
Maciej PolewczykFaculty of Medicine and Health Studies, Jan Kochanowski University, 25-369 Kielce, Poland.ORCID 0000-0002-1649-4696
Andrzej KutarskiDepartment of Cardiology, Medical University of Lublin, 20-509 Lublin, Poland.
John Paul II Hospital · PLJan Kochanowski University · PLRadom College · PLMedical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransvenous lead extraction (TLE) is a relatively safe procedure, but it may cause severe complications such as cardiac/vascular wall tear (CVWT) and tricuspid valve damage (TVD).

methodsThe risk factors for CVWT and TVD were examined based on an analysis of data of 1500 extraction procedures performed in two high-volume centers.

resultsThe total number of major complications was 33 (2.2%) and included 22 (1.5%) CVWT and 12 (0.8%) TVD (with one case of combined complication). Patients with hemorrhagic complications were younger, more often women, less often presenting low left ventricular ejection fraction (LVEF) and those who received their first cardiac implantable electronic device (CIED) earlier than the control group. A typical patient with CVWT was a pacemaker carrier, having more leads (including abandoned leads and excessive loops) with long implant duration and a history of multiple CIED-related procedures. The risk factors for TVD were similar to those for CVWT, but the patients were older and received their CIED about nine years earlier. Any form of tissue scar and technical problems were much more common in the two groups of patients with major complications.

conclusionsThe risk factors for CVWT and TVD are similar, and the most important ones are related to long lead dwell time and its consequences for the heart (various forms of fibrotic scarring). The occurrence of procedural complications does not affect long-term survival in patients undergoing lead extraction.

Indexed as

Defibrillators, ImplantablePacemaker, ArtificialDevice RemovalFemaleHumansLeadMaleRetrospective StudiesRisk FactorsStroke VolumeTreatment OutcomeTricuspid ValveVentricular Function, LeftLeadcardiac/vascular wall tearlead extraction-related major complicationstransvenous lead extractionworsening tricuspid regurgitation

Identifiers

PMID34501689
PMCPMC8431163
OpenAlexW3197808306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.